(Q42965001)

11 November 2017

title

Insulin, glucose and the increased risk of cancer in patients with type 2 diabetes (English)

1 reference

11 November 2017

1 reference

1

1 reference

11 November 2017

M Pollak

2

1 reference

11 November 2017

publication date

20 July 2010

1 reference

11 November 2017

1 reference

11 November 2017

volume

53

1 reference

11 November 2017

issue

10

1 reference

11 November 2017

page(s)

2086-2088

1 reference

Potential of peroxisome proliferator-activated receptor gamma antagonist compounds as therapeutic agents for a wide range of cancer types

11 November 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00125-010-1855-0

The Role of PPARs in Cancer

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00125-010-1855-0

Insulin receptor isoform A, a newly recognized, high-affinity insulin-like growth factor II receptor in fetal and cancer cells.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00125-010-1855-0

Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells

21 January 2018

1 reference

12 December 2020

Doses of insulin and its analogues and cancer occurrence in insulin-treated type 2 diabetic patients

1 reference

12 December 2020

Thiazolidinediones and the risk of lung, prostate, and colon cancer in patients with diabetes.

1 reference

12 December 2020

Influence of insulin deprivation on growth of the 7,12-dimethylbenz(a)anthracene-induced mammary carcinoma in rats subjected to alloxan diabetes and food restriction

1 reference

12 December 2020

A novel autocrine loop involving IGF-II and the insulin receptor isoform-A stimulates growth of thyroid cancer

1 reference

12 December 2020

Metformin blocks the stimulative effect of a high-energy diet on colon carcinoma growth in vivo and is associated with reduced expression of fatty acid synthase

1 reference

12 December 2020

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

1 reference

12 December 2020

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

12 December 2020

Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin

1 reference

12 December 2020

Associations of hyperglycemia and insulin usage with the risk of cancer in type 2 diabetes: the Hong Kong diabetes registry

1 reference

12 December 2020

Metformin inhibits mammalian target of rapamycin-dependent translation initiation in breast cancer cells

1 reference

12 December 2020

A prospective study of plasma C-peptide and colorectal cancer risk in men

1 reference

12 December 2020

Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study

1 reference

12 December 2020

Does insulin therapy promote, reduce, or have a neutral effect on cancers?

1 reference

12 December 2020

Insulin therapy and colorectal cancer risk among type 2 diabetes mellitus patients

1 reference

12 December 2020

Fasting serum glucose level and cancer risk in Korean men and women

1 reference

12 December 2020

Insulin and insulin-like growth factor signalling in neoplasia

1 reference

12 December 2020

Impact of prediagnosis smoking, alcohol, obesity, and insulin resistance on survival in male cancer patients: National Health Insurance Corporation Study.

1 reference

12 December 2020

Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women.

1 reference

12 December 2020

New users of metformin are at low risk of incident cancer: a cohort study among people with type 2 diabetes

1 reference

12 December 2020

Increased blood glucose and insulin, body size, and incident colorectal cancer

1 reference

12 December 2020

The influence of glucose-lowering therapies on cancer risk in type 2 diabetes

1 reference

12 December 2020

Glucose-lowering agents and cancer mortality rates in type 2 diabetes: assessing effects of time-varying exposure.

1 reference

12 December 2020

Do cancer cells care if their host is hungry?

1 reference

12 December 2020

Metformin and reduced risk of cancer in diabetic patients

1 reference

12 December 2020

Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group.

1 reference

12 December 2020

Diabetes, insulin use, and cancer risk: are observational studies part of the solution-or part of the problem?

1 reference

12 December 2020

Comment on: Yang et al. (2010) Associations of hyperglycemia and insulin usage with the risk of cancer in type 2 diabetes: the Hong Kong Diabetes Registry. Diabetes;59:1254-1260

1 reference

12 December 2020

Influence of glucose concentration on growth and formation of necrosis in spheroids derived from a human bladder cancer cell line

1 reference

12 December 2020

10.1007/S00125-010-1855-0

Identifiers

DOI

1 reference

11 November 2017

1 reference